(Q73032826)

English

Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience

scientific article published on 01 December 1996

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Phase II study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

V Westeel

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

P Jacoulet

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J L Breton

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

G Garnier

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

M Mercier

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

A Depierre

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

publication date

1 December 1996

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

61-73

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination effect of navelbine (vinorelbine ditartrate) with cisplatin against murine P388 leukemia and human lung carcinoma xenografts in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I-II study of vinorelbine (Navelbine) plus cisplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Vinorelbine versus vinorelbine plus cisplatin in advanced non-small cell lung cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase II study of vinorelbine, a new derivative of vinca alkaloid, for previously untreated advanced non-small cell lung cancer. Japan Vinorelbine Lung Cancer Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitomycin C etoposide and vinorelbine (MEV II) in the treatment of metastatic stage IV non small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Polychemotherapy in advanced non small cell lung cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase I/II trial of continuous infusion vinorelbine for advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2896%2900612-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0169-5002(96)00612-5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9017585%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73032826&oldid=1745697014"